Catherine Legraverend
- Molecular Biology top 10%
- Cancer Research top 5%
- Endocrinology, Diabetes and Metabolism top 5%
- Pharmacology top 1%
- Oncology top 10%
- Co-authors
- Daniel W. NebertAgneta ModePhilippe JayFrançois GerbeJan-Ακε GustafssonVirginie VivesFabien AgenèsChristian Delphin
- Topics
- Carcinogens and Genotoxicity Assessment (10 papers)Growth Hormone and Insulin-like Growth Factors (9 papers)Pharmacogenetics and Drug Metabolism (6 papers)
- Partner nations
- FranceUnited StatesSweden
In The Last Decade
Catherine Legraverend
36 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 99
- Molecular Biology 904
- Cancer Research 435
- Endocrinology, Diabetes and Metabolism 355
- Pharmacology 337
- Oncology 297
Countries citing papers authored by Catherine Legraverend
This map shows the geographic impact of Catherine Legraverend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Legraverend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Legraverend more than expected).
Fields of papers citing papers by Catherine Legraverend
This network shows the impact of papers produced by Catherine Legraverend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Legraverend. The network helps show where Catherine Legraverend may publish in the future.
Co-authorship network of co-authors of Catherine Legraverend
This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Legraverend. A scholar is included among the top collaborators of Catherine Legraverend based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Legraverend. Catherine Legraverend is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 188 | |
| 2 | 51 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 36 | |
| 6 | 282 | |
| 7 | 135 | |
| 8 | 135 | |
| 9 | 24 | |
| 10 | 22 | |
| 11 | 9 | |
| 12 | 37 | |
| 13 | 37 | |
| 14 | 92 | |
| 15 | 32 | |
| 16 | 58 | |
| 17 | 5 | |
| 18 | 64 | |
| 19 | 26 | |
| 20 | 23 |
About Catherine Legraverend
Catherine Legraverend is a scholar working on Cancer Research, Pharmacology and Endocrinology, Diabetes and Metabolism, having authored 36 papers that have together received 2.0k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (10 papers), Growth Hormone and Insulin-like Growth Factors (9 papers) and Pharmacogenetics and Drug Metabolism (6 papers). The work is most often cited by research in Developmental Neuroscience (259 citations), Pharmacology (337 citations) and Cancer Research (435 citations). Catherine Legraverend has collaborated with scholars based in France, United States and Sweden. Frequent co-authors include Daniel W. Nebert, Agneta Mode, Philippe Jay, François Gerbe, Jan-Ακε Gustafsson, Virginie Vives, Fabien Agenès, Christian Delphin, Jacques Baudier and Nicole Assard. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.